Clinical Study Center

Clinical research site in Seattle, Washington · 3417 EVANSTON AVE N STE 322, SEATTLE, WA 98103-8968 · (206) 257-9583

As of July 2026, 1 paid clinical trial is recruiting at Clinical Study Center in Seattle, Washington. Active studies at this site focus on Alpha-1 Antitrypsin Deficiency (AATD) alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 21, 2026.

Recruiting clinical trials at Clinical Study Center (1)

A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)

for Alpha-1 Antitrypsin Deficiency (AATD)

3 locations incl. Boston

Sponsor: Tessera Therapeutics, Inc.

Sex: All·Age: 18 - 70

Code: NCT07227207·Phase 1, Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

More research sites in Seattle

Seattle Children's Hospital (192 trials)
University of Washington (186 trials)
Fred Hutchinson Cancer Center (142 trials)
Fred Hutch/University of Washington Cancer Consortium (104 trials)
Swedish Medical Center-First Hill (67 trials)
University of Washington Medical Center (48 trials)
Swedish Medical Center (41 trials)
University of Washington Medical Center - Montlake (38 trials)
Swedish Cancer Institute (37 trials)
Fred Hutchinson Cancer Research Center (36 trials)

Explore more

Paid clinical trials in Seattle, WA · Washington clinical trials